Nakajima H, Hashimoto S, Nagao S, Kita Y, Khono M, Ogawa H, Abe S, Mizuno D
Gan. 1984 Mar;75(3):253-9.
DMG, a new polysaccharide with a well-characterized structure, isolated from the culture filtrate of an actinomycetes and then degraded by acid treatment, was tested for antitumor activity on allogeneic and syngeneic tumors in mice. In the allogeneic Ehrlich solid tumor system, DMG showed antitumor activity over a wide dose range, its optimal dose being 10-100 mg/kg. The optimal time of DMG administration was 1-2 weeks after tumor inoculation, but DMG was also effective when given before tumor inoculation. DMG was effective when given ip, sc, it (intratumorally) or iv. DMG also had antitumor effects on syngeneic tumors. It rapidly inhibited the growth of MM46 mammary carcinoma, MH134 hepatoma, and Meth A fibrosarcoma, and also inhibited spontaneous pulmonary metastases of B16-BL6 melanoma. However, it had no direct cytocidal action on tumor cells in vitro. Its antitumor activity was much less in athymic nude mice and in mice immunosuppressed by whole-body X-irradiation than in normal hosts.Thus, DMG was shown to exert antitumor activity via host-mediated mechanisms. Its antitumor activity is discussed in comparison with those of other antitumor polysaccharides.
从放线菌培养滤液中分离出一种结构已明确的新型多糖——二甲基葡糖胺(DMG),经酸处理降解后,对小鼠的同种异体和同基因肿瘤的抗肿瘤活性进行了测试。在同种异体艾氏实体瘤系统中,DMG在很宽的剂量范围内均显示出抗肿瘤活性,其最佳剂量为10 - 100毫克/千克。DMG给药的最佳时间是肿瘤接种后1 - 2周,但在肿瘤接种前给药也有效。DMG经腹腔注射、皮下注射、瘤内注射或静脉注射给药均有效。DMG对同基因肿瘤也有抗肿瘤作用。它能迅速抑制MM46乳腺癌、MH134肝癌和Meth A纤维肉瘤的生长,还能抑制B16 - BL6黑色素瘤的自发性肺转移。然而,它在体外对肿瘤细胞没有直接的杀细胞作用。与正常宿主相比,其在无胸腺裸鼠和经全身X射线照射免疫抑制的小鼠中的抗肿瘤活性要低得多。因此,DMG被证明是通过宿主介导的机制发挥抗肿瘤活性的。并将其抗肿瘤活性与其他抗肿瘤多糖的活性进行了比较讨论。